Cancer News

Recent advancements in cancer detection have emerged from the Mayo Clinic, where researchers have developed a groundbreaking blood test aimed at identifying germ cell tumors, the most prevalent form...

The University of Chicago has been awarded a substantial $66 million renewal grant from the National Cancer Institute (NCI) to continue its pivotal role in the NRG Oncology Statistics and Data...

The University of Chicago has been awarded a substantial $66 million grant from the National Cancer Institute (NCI) to continue its pivotal work with the NRG Oncology Statistics and Data Management...

In a significant advancement in cancer detection, researchers at the Mayo Clinic have unveiled a promising blood test designed to identify germ cell tumors, the most prevalent form of testicular...

In a significant advancement in oncology, researchers at the Mayo Clinic have unveiled a novel blood test that shows promise in detecting testicular cancer, particularly germ cell tumors, when...

Recent advancements in prostate cancer research have brought renewed hope for patients grappling with this challenging disease. A Phase 3 clinical trial, TALAPRO-3, has demonstrated that a novel...

In a significant advancement for prostate cancer treatment, a recent Phase 3 clinical trial led by Dr. Neeraj Agarwal has revealed that combining two drugs—talazoparib and enzalutamide—can reduce the...

Recent research from Johns Hopkins Medicine unveils a groundbreaking technique using magnetic particle imaging (MPI) that could significantly enhance the delivery of cell therapies for cancer and...

Recent research from UC San Diego has unveiled a significant breakthrough in understanding why some tumors resist immunotherapy, a critical tool in cancer treatment. The study highlights the role of...

Recent research from the University of California, San Diego, sheds light on a significant barrier to effective cancer treatment: the tumor microenvironment. This study highlights how a microRNA...

The American Society of Clinical Oncology (ASCO) Annual Meeting continues to be a pivotal platform for unveiling groundbreaking research in oncology. At the 2026 meeting, researchers from Roswell...

As the American Society of Clinical Oncology (ASCO) Annual Meeting unfolds, researchers from Roswell Park Comprehensive Cancer Center are making significant strides in the fields of breast cancer...

Pancreatic cancer has long been a formidable adversary in oncology, notorious for its late-stage diagnosis and grim survival statistics. However, recent research presented at the American Society of...

A recent study has unveiled a groundbreaking medication that could significantly enhance the survival rate for patients battling advanced pancreatic cancer. Presented at the American Society of...

An international study led by researchers at UCLA has unveiled exciting results for patients battling metastatic pancreatic cancer. The investigational targeted therapy, daraxonrasib, has...

Recent advancements in cancer treatment have brought renewed hope for patients battling metastatic pancreatic cancer, a notoriously aggressive form of the disease. An international study co-led by...

Recent findings from the Phase 3 BREAKWATER trial presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting have brought new hope for patients suffering from metastatic...

In a significant advancement for the treatment of advanced colorectal cancer, researchers from The University of Texas MD Anderson Cancer Center have unveiled promising results from the BREAKWATER...

Recent findings from a significant clinical trial have brought new hope for patients suffering from a rare genetic subtype of lung cancer, known as RET fusion-positive non-small cell lung cancer...

Recent advancements in cancer treatment have taken a significant leap forward, particularly for patients suffering from a rare genetic subtype of lung cancer. A new study co-led by researchers at the...